Liaoning Cheng Da Co., Ltd. (SHA:600739)

Market Cap	16.26B
Revenue (ttm)	11.29B
Net Income (ttm)	346.30M
Shares Out	1.52B
EPS (ttm)	0.23
PE Ratio	46.95
Forward PE	n/a
Dividend	0.10 (0.94%)
Ex-Dividend Date	Aug 9, 2024

Volume	7,805,068
Average Volume	12,337,015
Open	10.73
Previous Close	10.74
Day's Range	10.68 - 10.81
52-Week Range	7.13 - 13.71
Beta	0.90
RSI	47.85
Earnings Date	Apr 26, 2025

About Liaoning Cheng Da

Liaoning Cheng Da Co., Ltd. engages in supply chain trade, biopharmaceuticals, financial investment, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles and clothing, as well as trading of bulk commodities, such as coal, steel, and aquatic and agricultural products; and investment in securities, insurance and funds, and other financial service enterprises. It also offers human rabies vaccine and human JE inactivated vaccines, as well as exports its products to Egypt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1991
• Employees: 3,356
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600739

Financial Performance

In 2023, Liaoning Cheng Da's revenue was 10.78 billion, a decrease of -25.97% compared to the previous year's 14.56 billion. Earnings were 233.08 million, a decrease of -80.95%.